Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Sterling

Showing results (21-30 of 330) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|September 12, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisJason E Stout, Timothy R Sterling, C Robert Horsburgh
Current Opinion in HIV and AIDS|September 18, 2018
Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an updateApril C Pettit, Bryan E Shepherd, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Are we ready to shorten the treatment duration for non-cavitary pulmonary tuberculosis?Kwok-Chiu Chang, Timothy R Sterling, Wing-Wai Yew
Current Respiratory Care Reports|October 10, 2014
Diagnosis and treatment of latent tuberculosis infection: an updateAnna K Person, April C Pettit, Timothy R Sterling
AIDS Research and Human Retroviruses|January 10, 2014
Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewJessica L Castilho, Vlada V Melekhin, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2007
Stability of antituberculosis drugs mixed in foodCharles A Peloquin, David Durbin, James Childs, et al.
The Journal of Infectious Diseases|December 19, 2008
Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapyYukari C Manabe, Ronan Breen, Tara Perti, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2002
Reversible posterior leukoencephalopathy in an HIV-infected patient with thrombotic thrombocytopenic purpuraShelley L Sylvester, Luis A Diaz, John D Port, et al.
Pageof 33

Showing results (21-30 of 330) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|September 12, 2019
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related TuberculosisJason E Stout, Timothy R Sterling, C Robert Horsburgh
Current Opinion in HIV and AIDS|September 18, 2018
Treatment of drug-susceptible tuberculosis among people living with human immunodeficiency virus infection: an updateApril C Pettit, Bryan E Shepherd, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 17, 2013
Are we ready to shorten the treatment duration for non-cavitary pulmonary tuberculosis?Kwok-Chiu Chang, Timothy R Sterling, Wing-Wai Yew
Current Respiratory Care Reports|October 10, 2014
Diagnosis and treatment of latent tuberculosis infection: an updateAnna K Person, April C Pettit, Timothy R Sterling
AIDS Research and Human Retroviruses|January 10, 2014
Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewJessica L Castilho, Vlada V Melekhin, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 12, 2016
Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosisBrandon Eilertson, Fernanda Maruri, Amondrea Blackman, et al.
The Journal of Infectious Diseases|November 26, 2003
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort studyTimothy R Sterling, Richard E Chaisson, Jeanne Keruly, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2007
Stability of antituberculosis drugs mixed in foodCharles A Peloquin, David Durbin, James Childs, et al.
The Journal of Infectious Diseases|December 19, 2008
Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapyYukari C Manabe, Ronan Breen, Tara Perti, et al.
Scandinavian Journal of Infectious Diseases|October 11, 2002
Reversible posterior leukoencephalopathy in an HIV-infected patient with thrombotic thrombocytopenic purpuraShelley L Sylvester, Luis A Diaz, John D Port, et al.
Pageof 33